The changing face of noncardia gastric cancer incidence among US non-Hispanic whites

Journal of the National Cancer Institute

Volumn 110, Issue 6, 2018, Pages 608-615

  Anderson, William F ^a   Rabkin, Charles S ^a   Turner, Natalie ^a   Fraumeni, Joseph F ^a   Rosenberg, Philip S ^a   Camargo, M Constanza ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NORTH AMERICAN; PRIORITY JOURNAL; RACE; RISK FACTOR; STOMACH CANCER; TREND STUDY; UNITED STATES;

EID: 85046626054     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djx262     Document Type: Article

References (45)

1. Lagergren J, Smyth E, Cunningham D, et al. Oesophageal cancer. Lancet. In press.
2. Correa P. Gastric cancer: Overview. Gastroenterol Clin North Am. 2013;42(2): 211-217.
3. Strickland RG. The Sydney System: Auto-immune gastritis. J Gastroenterol Hepatol. 1991;6(3):238-243.
4. Rugge M, Genta RM, Di Mario F, et al. Gastric cancer as preventable disease. Clin Gastroenterol Hepatol. 2017;15(12):1833-1843.
5. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009;7(12):887-894.
6. Cremonini F, Gasbarrini A. Atopy, Helicobacter pylori and the hygiene hypothesis. Eur J Gastroenterol Hepatol. 2003;15(6):635-636.
7. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347(12):911-920.
8. Neumann WL, Coss E, Rugge M, et al. Autoimmune atrophic gastritis-pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10(9):529-541.
9. Hwang LJ, Altekruse S, Adamo M, et al. SEER and NAACCR data completeness methods: how do they impact data quality in Central Cancer Registries? J Registry Manag. 2012;39(4):185-186.
10. SEER*Stat. Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.gov/seerstat).
11. Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-351.
12. Rosenberg PS, Barker KA, Anderson WF. Estrogen receptor status and the future burden of invasive and in-situ breast cancers in the United States. J Natl Cancer Inst. 2015;107(9):djv159.
13. McCullagh P, Nelder JA. Generalized Linear Models. New York: Chapman and Hall; 1989.
14. Rosenberg PS, Check DP, Anderson WF. A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemio Biomarkers Prev. 2014;23(11):2296-2302.
15. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31-49.
16. Ennis SR, Rio-Vargas M, Albert NG. The Hispanic population: 2010. https://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf. Accessed May 30, 2017.
17. Anderson WF, Camargo MC, Fraumeni JF Jr, et al. Age-specific trends in the incidence of noncardia gastric cancer in US adults. JAMA. 2010;303(17): 1723-1728.
18. Camargo MC, Anderson WF, King JB, et al. Divergent trends for gastric cancer incidence by anatomic subsite in U.S. adults. Gut. 2011;60:1644-1649.
19. Luo G, Zhang Y, Guo P, et al. Global patterns and trends in stomach cancer incidence: Age, period and birth cohort analysis. Int J Cancer. 2017;141(7):1333-1344.
20. Cardenas VM, Graham DY. Smoking and Helicobacter pylori infection in a sample of U.S. adults. Epidemiology. 2005;16(4):586-590.
21. Song H, Held M, Sandin S, et al. Increase in the prevalence of atrophic gastritis among adults age 35 to 44 years old in northern Sweden between 1990 and 2009. Clin Gastroenterol Hepatol. 2015;13(9):1592-1600, e1.
22. Minalyan A, Benhammou JN, Artashesyan A, et al. Autoimmune atrophic gastritis: Current perspectives. Clin Exp Gastroenterol. 2017;10:19-27.
23. Coati I, Fassan M, Farinati F, et al. Autoimmune gastritis: Pathologist's viewpoint. World J Gastroenterol. 2015;21(42):12179-12189.
24. Smyk DS, Koutsoumpas AL, Mytilinaiou MG, et al. Helicobacter pylori and autoimmune disease: Cause or bystander. World J Gastroenterol. 2014;20(3): 613-629.
25. Qvigstad G, Qvigstad T, Westre B, et al. Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia. APMIS. 2002;110(2):132-139.
26. Modlin IM, Shapiro MD, Kidd M. Carcinoid tumors and fibrosis: An association with no explanation. Am J Gastroenterol. 2004;99(12):2466-2478.
27. Murphy G, Dawsey SM, Engels EA, et al. Cancer risk after pernicious anemia in the US elderly population. Clin Gastroenterol Hepatol. 2015;13(13):2282-2289, e1-e4.
28. Blaser MJ. Helicobacters are indigenous to the human stomach: Duodenal ulceration is due to changes in gastric microecology in the modern era. Gut. 1998;43(5):721-727.
29. Frenk SM, Kit BK, Lukacs SL, et al. Trends in the use of prescription antibiotics: NHANES 1999-2012. J Antimicrob Chemother. 2016;71(1):251-256.
30. Hicks LA, Bartoces MG, Roberts RM, et al. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. Clin Infect Dis. 2015;60(9):1308-1316.
31. Cao Y, Wu K, Mehta R, et al. Long-term use of antibiotics and risk of colorectal adenoma. Gut. In press.
32. Holford TR, Levy DT, McKay LA, et al. Patterns of birth cohort-specific smoking histories, 1965-2009. Am J Prev Med. 2014;46(2):e31-e37.
33. Fulgoni VL 3rd, Agarwal S, Spence L, et al. Sodium intake in US ethnic subgroups and potential impact of a new sodium reduction technology: NHANES Dietary Modeling. Nutr J. 2014;13(1):120.
34. Esser MB, Clayton H, Demissie Z, et al. Current and binge drinking among high school students - United States, 1991-2015. MMWR Morb Mortal Wkly Rep. 2017;66(18):474-478.
35. Minalyan A, Gabrielyan L, Scott D, et al. The gastric and intestinal microbiome: Role of proton pump inhibitors. Curr Gastroenterol Rep. 2017;19(8):42.
36. Kuipers EJ. Proton pump inhibitors and Helicobacter pylori gastritis: Friends or foes? Basic Clin Pharmacol Toxicol. 2006;99(3):187-194.
37. Wennerstrom ECM, Simonsen J, Camargo MC, et al. Acid-suppressing therapies and subsite-specific risk of stomach cancer. Br J Cancer. 2017;116(9): 1234-1238.
38. Murphy G, Pfeiffer R, Camargo MC, et al. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology. 2009;137(3):824-833.
39. Edgren G, Liang L, Adami HO, et al. Enigmatic sex disparities in cancer incidence. Eur J Epidemiol. 2012;27(3):187-196.
40. Sipponen P, Correa P. Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: Etiologic hypothesis. Gastric Cancer. 2002;5(4):213-219.
41. Cook MB, Dawsey SM, Freedman ND, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev. 2009;14(4):1174-1182.
42. Freedman ND, Derakhshan MH, Abnet CC, et al. Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women. Eur J Cancer. 2010;46(13): 2473-2478.
43. Camargo MC, Goto Y, Zabaleta J, et al. Sex hormones, hormonal interventions, and gastric cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers Prev. 2012;21(1):20-38.
44. Nichols HB, Trentham-Dietz A, Hampton JM, et al. From menarche to menopause: Trends among US Women born from 1912 to 1969. Am J Epidemiol. 2006;164(10):1003-1011.
45. Camargo MC, Freedman ND, Hollenbeck AR, et al. Height, weight, and body mass index associations with gastric cancer subsites. Gastric Cancer. 2014; 17(3):463-468.